Library

Protocol

L-Carnitine (200mg Vial)

Complete dosage protocol and reconstitution guide for L-Carnitine (200mg Vial).

Updated November 26, 2025 Research guide Research information only
Open calculator preset Build protocol outline TNHL options
Educational reference only. TNHL calculates and organizes user-entered values; it does not diagnose, prescribe, recommend doses, or replace guidance from a qualified professional.
MechanismL-Carnitine is an amino acid derivative essential for fatty acid transport into mitochondria, where it facilitates β-oxidation and energy production [1] . Subcutaneous administration bypasses intestinal conversion to trimethylamine-N-oxide (TMAO), a metabolite associated with cardiovascular concerns [4] , while providing 100% bioavailability compared to 5–18% for large oral doses [3] .
Dosing50–100 mg once daily (gradual titration); advanced protocols may use up to 200 mg.
ReconstitutionAdd 2.0 mL diluent to a 200 mg vial.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2–4 weeks; do not freeze reconstituted solution.

Calculator preset

Run the vial math before tracking.

At 100 mg/mL, 1 unit = 1 mg (0.01 mL); 50 mg = 50 units and 100 mg = 100 units on a U-100 syringe.

Calculate this vial

01 · At a glance

Quickstart Highlights

L-Carnitine is an amino acid derivative essential for fatty acid transport into mitochondria, where it facilitates β-oxidation and energy production [1] . Subcutaneous administration bypasses intestinal conversion to trimethylamine-N-oxide (TMAO), a metabolite associated with cardiovascular concerns [4] , while providing 100% bioavailability compared to 5–18% for large oral doses [3] . This educational protocol presents a once-daily subcutaneous approach optimized for insulin-syringe measurements.

ReconstituteAdd 2.0 mL bacteriostatic water → 100 mg/mL concentration (1 unit = 1 mg).
Reference dose50–100 mg once daily (gradual titration); advanced protocols may use up to 200 mg.
Easy measuringAt 100 mg/mL, 1 unit = 1 mg (0.01 mL); 50 mg = 50 units and 100 mg = 100 units on a U-100 syringe.
StorageLyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2–4 weeks; do not freeze reconstituted solution.
Start with sterile preparation, storage, and injection-site basics before using any calculator output. TNHL is a tracking and education tool only.

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Approach (2.0 mL = 100 mg/mL)

Phase / setup Dose & frequency Volume / units
Weeks 1–250 mg50 units (0.50 mL)
Weeks 3–8100 mg100 units (1.0 mL)
Weeks 9–12100 mg100 units (1.0 mL)

50–100 mg once daily (gradual titration); advanced protocols may use up to 200 mg.

Reconstitution Steps

  1. Draw 2.0 mL bacteriostatic water (0.9% benzyl alcohol) with a sterile syringe.
  2. Inject slowly down the vial wall to minimize foaming; avoid direct stream onto powder.
  3. Gently swirl or roll the vial until powder is fully dissolved (do not shake vigorously).
  4. Label vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.
  5. Use within 2–4 weeks ; bacteriostatic water preservative inhibits microbial growth during multi-dose use [6] .

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Peptide Vials 8 weeks (56 days @ 100 mg/day) ≈ 28 vials
  • 12 weeks (84 days @ 100 mg/day) ≈ 42 vials
  • 16 weeks (112 days @ 100 mg/day) ≈ 56 vials Note: Each 200 mg vial reconstituted at 2.0 mL provides two 100 mg doses (or four 50 mg doses).
Insulin Syringes Per week: 7 syringes (1/day)
  • 8 weeks: 56 syringes
  • 12 weeks: 84 syringes
  • 16 weeks: 112 syringes
Bacteriostatic Water Use 2.0 mL per vial for reconstitution.
  • 8 weeks (28 vials): 56 mL → 6 × 10 mL bottles
  • 12 weeks (42 vials): 84 mL → 9 × 10 mL bottles
  • 16 weeks (56 vials): 112 mL → 12 × 10 mL bottles
Alcohol Swabs One for vial stopper + one for injection site each day.
  • Per week: 14 swabs (2/day)
  • 8 weeks: 112 swabs → recommend 2 × 100-count boxes
  • 12 weeks: 168 swabs → recommend 2 × 100-count boxes
  • 16 weeks: 224 swabs → recommend 3 × 100-count boxes Sharps Container: For safe disposal of used syringes and needles.

Protocol Overview

  • Goal: Support mitochondrial fatty acid oxidation and energy metabolism while avoiding TMAO production associated with oral dosing [4] .
  • Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
  • Dose Range: 50–100 mg daily with gradual titration; advanced protocols may use up to 200 mg daily.
  • Reconstitution: 2.0 mL per 200 mg vial (100 mg/mL) for precise 1:1 unit-to-milligram measurement.
  • Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw cycles.

Dosing Protocol

  • Suggested daily titration approach based on clinical literature.
  • Start: 50 mg daily for Weeks 1–2 to assess tolerance and monitor for injection-site reactions [8] .
  • Maintenance: Increase to 100 mg daily from Week 3 onward; this is a reasonable maintenance dose for most research purposes [8] .
  • Advanced: Up to 200 mg daily for robust experimental protocols, if clearly supported by research findings [8] .
  • Frequency: Once per day subcutaneously (any consistent time; morning or pre-exercise commonly used).
  • Cycle Length: 8–12 weeks; optional extension to 16 weeks with continued monitoring.
  • Site Rotation: Rotate injection sites systematically (abdomen, thighs, upper arms) to prevent tissue irritation.

Storage Instructions

  • Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2–4 weeks; do not freeze reconstituted solution.
  • Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw cycles.
  • Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

04 · Good to know

Important Notes

  • Practical considerations for consistency, safety, and optimal results.
  • Sterile technique: Use new sterile insulin syringes for each injection; never reuse needles or syringes.
  • Site rotation: Rotate injection sites systematically (abdomen at least 2 inches from navel, outer thighs, upper arms) to reduce local irritation and prevent lipohypertrophy [11] .
  • Injection speed: Inject slowly (over several seconds) to minimize discomfort; wait 5–10 seconds before withdrawing needle to prevent leakage [6] .
  • Room temperature: Allow refrigerated solution to warm slightly (to room temperature) before injecting to reduce pain [6] .
  • Documentation: Keep a log of daily dose, injection site, and any observations (tolerance, energy levels) to maintain consistency.
  • Sharps disposal: Immediately dispose of used needles and syringes in an approved sharps container; never recap needles by hand.

05 · How it works

How This Works

L-Carnitine is an amino acid derivative essential for fatty acid transport into mitochondria, where it facilitates β-oxidation and energy production [1] .

Subcutaneous administration bypasses intestinal conversion to trimethylamine-N-oxide (TMAO), a metabolite associated with cardiovascular concerns [4] , while providing 100% bioavailability compared to 5–18% for large oral doses [3] .

This educational protocol presents a once-daily subcutaneous approach optimized for insulin-syringe measurements.

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

  • Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
  • Track body metrics only if they are relevant to the user's goal and approved data sources.
  • Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

  • L-Carnitine observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
  • This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

Pre-injection preparation
  • Wash hands with soap and water.
  • Wipe the vial stopper and chosen site with alcohol, then let both dry.
  • Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
Injection procedure
  • Use the route and needle technique directed by a qualified professional or product instructions.
  • For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
  • Do not reuse needles or syringes.
Post-injection care
  • Dispose of sharps in a puncture-resistant container.
  • Return stored items promptly to the correct temperature.
  • Log dose, site, date, time, inventory change, and any observation.

09 · Evidence

References

TNHL options

Peptide collections stay passive.

Open the TNHL Stan Store option that fits the order size. Product details, checkout, and fulfillment stay off-site.